Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice

Journal of Infectious Diseases

Volumn 186, Issue 8, 2002, Pages 1115-1121

  Cutter, David ^a,b   Mason, Kathryn W ^c   Howell, Alan P ^c   Fink, Doran L ^a,b   Green, Bruce A ^c   St Geme, Joseph W ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL PROTEIN; CHOLERA TOXIN; HAEMOPHILUS VACCINE; PROTEIN HAP; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EXTRACELLULAR SPACE; FEMALE; HAEMOPHILUS INFLUENZAE; IMMUNIZATION; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PURIFICATION; RHINOPHARYNGITIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL ADHESION; BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; CELL LINE; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; NASOPHARYNX; SERINE ENDOPEPTIDASES;

EID: 0037108663     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/344233     Document Type: Article

References (35)

1. Turk DC. The pathogenicity of Haemophilus influenzae. J Med Microbiol 1984;18:1-16.28.
2. Murphy TF, Bernstein JM, Dryja DM, Campagnari AA, Apicella MA. Outer membrane protein and lipooligosaccharide analysis of paired nasopharyngeal and middle ear isolates in otitis media due to nontypeable Haemophilus influenzae: pathogenic and epidemiologic observations. J Infect Dis 1987;156:723-31.
3. Rao VK, Krasan GP, Hendrixson DR, Dawid S, St Geme JW III. Molecular determinants of the pathogenesis of disease due to non-typeable Haemophilus influenzae. FEMS Microbiol Rev 1999;23:99-129.
4. Hendrixson DR, St Geme JW III. The Haemophilus influenzae Hap serine protease promotes adherence and microcolony formation, potentiated by a soluble host protein. Mol Cell 1998;2:841-50.
5. St Geme JW III, de la Morena ML, Falkow S. A Haemophilus influenzae IgA protease-like protein promotes intimate interaction with human epithelial cells. Mol Microbiol 1994;14:217-33.
6. Henderson IR, Navarro-Garcia F, Nataro JP. The great escape: structure and function of the autotransporter proteins. Trends Microbiol 1998;6:370-7.
7. Hendrixson DR, de la Morena ML, Stathopoulos C, St. Geme JW III. Structural determinants of processing and secretion of the Haemophilus influenzae Hap protein. Mol Microbiol 1997;26:505-18.
8. Musser JM, Barenkamp SJ, Granoff DM, Selander RK. Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect Immun 1986;52:183-91.
9. Bolduc GR, Bouchet V, Jiang RZ, et al. Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach. Infect Immun 2000;68:4505-17.
10. Haase EM, Campagnari AA, Sarwar J, et al. Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae. Infect Immun 1991;59:1278-84.
11. Loeb MR. Protection of infant rats from Haemophilus influenzae type b infection by antiserum to purified outer membrane protein a. Infect Immun 1987;55:2612-8.
12. Akkoyunlu M, Forsgren A. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats. APMIS 1996;104:709-17.
13. DeMaria TF, Murwin DM, Leake ER. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media. Infect Immun 1996;64:5187-92.
14. Green BA. Farley JE, Quinn-Dey T, Deich RA, Zlotnick GW. The e (P4) outer membrane protein of Haemophilus influenzae: biologic activity of anti-e serum and cloning and sequencing of the structural gene. Infect Immun 1991;59:3191-8.
15. Green BA, Quinn-Dey T, Zlotnick GW. Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b. Infect Immun 1987;55:2878-83.
16. Sanders JD, Cope LD, Jarosik GP, et al. Reconstitution of a porin-deficient mutant of Haemophilus influenzae type b with a porin gene from nontypeable H. influenzae. Infect Immun 1993;61:3966-75.
17. Clemans DL, Bauer RJ, Hanson JA, et al. Induction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae. Infect Immun 2000;68:4430-40.
18. Setlow JK, Brown DC, Boling ME, Mattingly A, Gordon MP. Repair of deoxyribonucleic acid in Haemophilus influenzae. I. X-ray sensitivity of ultraviolet-sensitive mutants and their behavior as hosts to ultraviolet-irradiated bacteriophage and transforming deoxyribonucleic acid. J Bacteriol 1968;95:546-58.
19. Fleischmann RD, Adams MD, White O, et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 1995;269:496-512.
20. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
21. Tomb J-F, Barcak GJ, Chandler MS, Redfield RJ, Smith HO. Transposon mutagenesis, characterization, and cloning of transformation genes of Haemophilus influenzae Rd. J Bacteriol 1989;171:3796-802.
22. St Geme JW III, Falkow S. Haemophilus influenzae adheres to and enters cultured human epithelial cells. Infect Immun 1990;58:4036-44.
23. Dower WJ, Miller JF, Ragsdale CW. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res 1988;16:6127-45.
24. Herriott RM. Meyer EM, Vogt M. Defined non-growth media for stage II development of competence in Haemophilus influenzae. J Bacteriol 1970;101:517-24.
25. Carlone GM, Thomas ML, Rumschlag HS, Sottnek FO. Rapid procedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species. J Clin Microbiol 1986;24:330-2.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
27. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4.
28. St Geme JW III, Falkow S, Barenkamp SJ. High-molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells. Proc Natl Acad Sci USA 1993;90:2875-9.
29. Tebbey PW, Scheuer CA, Peek JA, et al. Effective mucosal immunization against respiratory syncytial virus using a genetically detoxified cholera holotoxin, CT-E29H. Vaccine 2000;18:2723-34.
30. Conover WJ, Iman RL. On some alternative procedures using ranks of experimental designs. Commun Stat A 1975;5:1349-68.
31. Conover WJ. Iman RL. Rank transformation as a bridge between parametric and non-parametric statistics. Am Stat 1981;35:124-33.
32. Fink DL, Cope LD, Hansen EJ, St Geme JW III. The Hoemophilus influenzae Hap autotransporter is a chymotrypsin clan serine protease and undergoes autoproteolysis via an intermolecular mechanism. J Biol Chem 2001;276:39492-500.
33. Walker RI. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994;12:387-400.
34. Snider DP. The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Crit Rev Immunol 1995;15:317-48.
35. Hotomi M, Saito S, Yamanaka N. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin. Vaccine 1998;16:1950-6.